SanBio publishes interim data from traumatic brain injury trial
The SB623 treatment was observed to be safe and well-tolerated. Credit: MasterTux from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
